Cost-effectiveness of fibronectin testing in a triage in women with threatened preterm labor: Alleviation of pregnancy outcome by suspending tocolysis in early labor (APOSTEL-I trial)

Jolande Y. Vis*, Femke F. Wilms, Martijn A. Oudijk, Martina M. Porath, Hubertina C.J. Scheepers, Kitty W.M. Bloemenkamp, Annemiek C. Bolte, Jérôme Cornette, Jan B. Derks, Johannes J. Duvekot, Jim van Eyck, Anneke Kwee, Brent C. Opmeer, Maria G. van Pampus, Fred K. Lotgering, Sicco A. Scherjon, Krystyna M. Sollie, Marc E.A. Spaanderman, Christine Willekes, Joris A.M. van der PostBen W.J. Mol

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

23 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Cost-effectiveness of fibronectin testing in a triage in women with threatened preterm labor: Alleviation of pregnancy outcome by suspending tocolysis in early labor (APOSTEL-I trial)'. Together they form a unique fingerprint.

Medicine & Life Sciences